Immunohistochemistry (IHC) staining of tissue sections demonstrated an overt elevation in the protein levels of SLC7A5, MAT2A, MAT2B, and AHCY in clinical ESCC tissues as relative to NATs in all three validation cohorts (Supplementary Fig. S2C–H). This evidence concerns the gene SLC7A5 and esophageal squamous cell carcinoma.